Best Dental M&A Advisors and Practice Transition Brokers in 2026
Co-founder at Peony. Former M&A at Nomura, early-stage VC at Backed VC, and growth-equity / secondaries investor at Target Global. I write about investors, fundraising, and deal advisors from the deal-side perspective I spent years in.
Best Dental M&A Advisors and Practice Transition Brokers in 2026
Quick answer. There is no single "best" dental M&A advisor, because a $900K solo practice and a $9M group need different firms. At the small end, dental practice transition brokers run a listings-and-matchmaking model — the national names that describe their own coverage include Henry Schein Dental Practice Transitions, ddsmatch, AFTCO, Professional Transition Strategies, US Dental Transitions, Omni Practice Group, and PARAGON, with CTC Associates (Mountain West) and Practice Impact (Ohio) regional. Above roughly $1.5M of revenue, DSO-scale sell-side advisors run competitive processes — TUSK Practice Sales, Large Practice Sales, Skytale Group, Practice Exchange, McLerran & Associates, plus Provident Healthcare Partners and Viper Equity Partners. Pick by size and by who pays the firm — supplier-owned, dual-representation, or seller-exclusive — not by a "best" label.
Last updated: August 2026
I'm Sean Yu, co-founder of Peony. I have spent my career on the deal side, and I have watched a lot of practice owners start their search by typing "best dental practice broker" into a search bar and getting back a ranked list of ten firms as if a single league table existed. It does not. The firm that is right for a solo general dentist selling to a younger associate is almost never the firm that is right for a five-location group running a competitive process across four DSOs, and the reverse is just as true. Dental representation is segmented by the size of your practice and by the model the firm runs — and, critically, by who actually pays the firm, because that shapes whose side it is on. I run Peony, a data room company serving 6,800+ customers, so I see the document side of these processes across brokers and advisories both. This guide is an honest, segmented directory: the transition-broker bench, the DSO-scale advisory bench, how the multi-mandate broker model works, how to vet a firm, and how the confidentiality actually gets run. Almost everything below is about the firms and the process, not the software, and I will tell you plainly where the software does not matter.
A note on how this guide is scoped, because it matters for accuracy. Every firm named here comes from a directory of dental transition brokers and advisors I verified from each firm's own site, and every claim about a firm is stated the way the firm states it. Self-published track records are attributed as such. Where a firm publishes fee language, I quote it; where a firm is silent on fees, I say so rather than invent a "typical" commission. And this post deliberately stops at the dental-specific bench. The national, multi-vertical healthcare investment banks that handle the largest multi-site platform deals — including Provident Healthcare Partners, Cross Keys Capital, and Physician Growth Partners for large physician-practice-management and DSO transactions — are the subject of our best healthcare M&A advisors guide, which is the broader healthcare bench this guide links up to.
Do you need a dental broker, an M&A advisor, or neither?
The right intermediary is a function of your practice size and your most likely buyer, and the market sorts roughly into three bands: a transition broker for a solo-to-small-group sale, a dental M&A advisor for a group running a competitive process, and no intermediary at all for an internal sale to an associate you already trust. Get this decision right before you shortlist a single firm, because hiring the wrong tier is the most expensive mistake in the whole exercise — a broker cannot run a platform auction, and a platform advisor will not take a single-doctor listing.
At the small end sits the transition broker. If you are a solo general dentist or a two-to-three-location owner selling to another dentist, or fielding an approach from a single DSO, a transition broker is usually the fit. These firms run a listings-and-matchmaking model: they value the practice, market it under a blind profile, gate buyers behind an NDA, and introduce you to buyers from a pool they already maintain. None of the transition brokers named below publishes a stated revenue floor, which is consistent with a market built around individual practices rather than platforms.
In the middle sits the dental M&A advisor. Once your group is large enough that multiple DSOs and private-equity-backed platforms would compete for it, a sell-side advisor running a structured, competitive process usually beats a listing, because the competition is what moves price. The clearest published marker of this transition is TUSK Practice Sales, which states on its site that it is "the exclusive sell-side advisor for dental practice owners generating over $1.5M of revenue." Above that, and especially at true platform scale, advisories such as Large Practice Sales, Practice Exchange, McLerran & Associates, and Skytale Group run competitive DSO processes, and the largest multi-site platforms move to the healthcare investment banks in the sibling guide.
And sometimes the answer is neither. If you are selling to an associate you already trust, you may need no broker and no advisor at all — just a transition attorney and a CPA who do dental work. There is no competitor to guard against, no auction to run, and no buyer pool to tap. The valuation and process mechanics for that path live in our how to sell a dental practice guide, and if what triggered your search is a DSO offer already on the table, our DSO offer evaluation guide decodes the structure before you decide whether you even need representation.
One framing note before the benches. The size bands overlap, and a practice at the boundary can legitimately go either way. A $1.6M-collections practice with one likely local buyer might be well served by a broker's matchmaking, while a $1.4M practice sitting in a market three DSOs are actively rolling up might be better off with an advisor running a competitive process. Size is the first cut; buyer depth is the tiebreaker.
Who are the dental practice transition brokers?
The transition-broker bench is made up of national and large-regional firms that list and match solo-to-small-group practices, most of them silent on fees and each carrying a distinct model you should understand before you sign. The table maps them; the paragraphs that follow profile each one in its own words. I am presenting them alphabetically within coverage type, not ranked, because there is no single best — the right one depends on your geography, your practice size, and which conflict model you are comfortable with.
| Firm | Coverage | Lane | Model notes |
|---|---|---|---|
| AFTCO | National | Solo to small group | Founded 1968; describes dual representation of buyer and seller |
| CTC Associates | Mountain West (regional) | Solo to small group | Publishes fee language ("less than 10% of the selling price") |
| ddsmatch | National with regional offices | Solo to small group; associate placement; DSO representation | Trademarked "Trusted Transition Process"; no fees published |
| Henry Schein Dental Practice Transitions | 50 states plus D.C. (per its site) | Solo to small group | Supplier-owned: the transitions arm of distributor Henry Schein |
| Omni Practice Group | National | Practice sales, valuations, real estate | Not dental-exclusive (dental, veterinary, medical) |
| PARAGON Dental Practice Transitions | 50 states plus D.C. (per its site) | Solo to small group; buy-ins and buy-outs | Describes dual representation ("win/win transactions") |
| Practice Impact | Ohio (regional) | Solo to small group; associate buy-ins | New Albany, Ohio; NAPB member; no fees published |
| Professional Transition Strategies | National | Brokerage, valuations, buyer and seller rep | Publishes fee language ("only one broker fee"); 30-day listing agreements |
| US Dental Transitions | National (emphasis FL, AL, GA, NC) | Buying, selling, merging; associate placement | Founded 1998, Suwanee, GA; database of 125,000+ dentists (per its site) |
Henry Schein Dental Practice Transitions is the transition arm of Henry Schein, Inc., the dental distributor, and I want to name that plainly because it is the single most important fact about the firm: it is supplier-owned. Its site offers valuations, listings, and full transaction management, describes "consultants covering all 50 states plus Washington, D.C.," and styles the practice as "America's #1 Dental Broker." It does not publish fees. The supplier affiliation is not a reason to avoid the firm, but it is a reason to ask directly how the transitions business relates to the distribution business and who the firm is representing in your deal. Its own guidance is candid on valuation, incidentally: Henry Schein's transition arm explicitly declines to publish a single percentage or multiple, warning that such references "cannot replace a professional valuation" — a caveat worth holding onto no matter which broker you use.
ddsmatch runs practice sales, associate placement, and DSO representation nationally through regional offices, marketing a trademarked "Trusted Transition Process" and "Practice Optimizer Experience." It does not publish fees, and its site does not state a founding date or headquarters. For an owner who wants a structured, brand-name matchmaking process with national reach, ddsmatch is one of the larger names in the category.
AFTCO describes itself on its site as, in its words, the "oldest and largest dental practice transition consulting network in the United States," founded in 1968, handling purchasing, selling, and merging. The model fact you must not miss: AFTCO practices dual representation, representing both buyer and seller, which it frames on its own site as "Equitable Transactions through Dual Representation." That is a legitimate and long-established approach, but it means the firm is not exclusively your advocate, so weigh it against seller-only alternatives if single-sided representation matters to you.
Professional Transition Strategies (PTS) offers brokerage, valuations, and both buyer and seller representation nationally, and it is one of the few firms here that publishes fee language: it states "no upfront costs or retainer fees, only one broker fee," and it works on 30-day listing agreements rather than the standard one-year term — a genuinely differentiated commitment structure. Its site does not state a founding date or headquarters beyond a Colorado phone presence. For a seller who values fee transparency and a short listing commitment, PTS is worth a call.
US Dental Transitions handles buying, selling, and merging plus associate placements, with national reach and an emphasis on Florida, Alabama, Georgia, and North Carolina. Founded in 1998 and headquartered in Suwanee, Georgia, the firm states on its site that it maintains a "database of 125,000+ dentists" and has "consulted over 6,000 dentists." Those are the firm's own figures, so treat them as such — but a deep, named buyer database is exactly what the matchmaking model runs on, so the claim is at least on-point for the model.
Omni Practice Group offers transitions, sales, valuations, and buyer representation, and it also does commercial real estate. One caveat to flag: Omni is not dental-exclusive — it works dental, veterinary, and medical practices — so if you want a firm that does nothing but dental every day, factor that in. The firm does not publish fees, and its fetched page does not state a founding date or footprint detail.
PARAGON Dental Practice Transitions covers buying, selling, and merging, plus equity associateships and buy-ins and buy-outs, describing consultants across "all 50 U.S. states plus Washington D.C." Like AFTCO, PARAGON describes a dual-representation approach, framing its work around "win/win transactions" on its site. It does not publish fees. The same guidance applies: dual representation is established practice, but know that you are not hiring a seller-only advocate.
Practice Impact is the regional specialist here, working Ohio only from a headquarters in New Albany. It offers valuations, sales and transitions, and associate buy-ins, and it is a member of the NAPB (an association, not an ownership relationship). It does not publish fees. For an Ohio owner who wants a firm concentrated in the local market rather than a national brand flying in, Practice Impact is the geographically native option.
CTC Associates is the other explicit regional, covering the Mountain West — Colorado, Utah, Idaho, Wyoming, and New Mexico, with extended reach into Arizona, Washington, Alaska, and Hawaii. It offers sales, appraisals, buyer representation, and associateships, and it publishes fee language: it describes "an adjusted percentage option, normally equating to less than 10% of the selling price." The firm states it was founded in 1988 and has completed "over 2,000 transitions since 1988" — its own figure, attributed. For a Mountain West seller who wants regional depth and a stated fee approach, CTC is the reference name in that footprint.
Who advises on DSO-scale and dental platform deals?
Once a practice is large enough to draw competitive interest from DSOs and private-equity-backed platforms, the sell-side advisory tier takes over, running structured competitive processes rather than listings — and this bench is where the seller-exclusive, conflict-free positioning becomes a marketed differentiator. These firms describe a different job than the transition brokers above: not matching a practice to a known buyer, but running a process designed to create competition among many buyers. The table maps them; the profiles follow. Again, alphabetical within the tier, not ranked.
| Firm | Coverage | Lane | Model notes |
|---|---|---|---|
| Large Practice Sales | National ("29+ states" per its site) | IDSO majority-recap transactions | Doctor retains operational control; no fees published |
| McLerran & Associates | National | Dental sell-side M&A and brokerage; DSO affiliations | Positions as sell-side advocate; bridges broker and advisory tiers |
| Practice Exchange | Northeast/Mid-Atlantic core, expanding nationally | Sell-side rep to DSOs, mini-DSOs, IDSOs | Seller-exclusive ("never buyers"); success fee only |
| Provident Healthcare Partners | National | Healthcare investment bank; dental/DSO active vertical | Sell-side M&A and financing; buyers include PE and strategics |
| Skytale Group | National | Investment banking plus management consulting | Principals registered IB agents (Burch & Company, FINRA/SIPC) |
| TUSK Practice Sales | National | Sell-side M&A advisor, ~90% dentistry | Revenue floor over $1.5M; no retainers, paid at close; states conflict-free |
| Viper Equity Partners | National | Aligns practices with DSOs and PE | States exclusive relationships with PE-funded DSOs |
TUSK Practice Sales is a sell-side M&A advisor that states roughly 90% of its work is in dentistry, and it is the clearest published example of the revenue-floor logic that separates this tier from the brokers: TUSK describes itself as "the exclusive sell-side advisor for dental practice owners generating over $1.5M of revenue." On fees, it states "no retainers, paid at close." And on conflicts, it markets independence directly, stating it has "no financial ties or investments from DSOs" and describing itself as "conflict-free." For an owner above that revenue floor who specifically wants a seller-only advisor with no DSO ownership entanglements, TUSK's positioning is built for exactly that concern. (TUSK also publishes market research; its Q2 2026 Dental Market Report is one of the sources behind the buyer-appetite figures advisors cite for 2026.)
Large Practice Sales (LPS) specializes in the Invisible Dental Support Organization (IDSO) structure — a model in which the buyer acquires a majority stake while the selling doctor retains operational control and rolls equity, rather than a full sale into a branded DSO. LPS describes itself as "the Largest IDSO Transaction Advisor" and states it signed "$500 million of new clients" across "29 states" in 2025 (its own figures, attributed). Its marketing describes competitive bidding producing valuations it frames as "2x and 3x" traditional levels — again the firm's own characterization, which you should test against a formal valuation rather than take as a benchmark. It does not publish fees. For an owner specifically interested in a majority-recap-with-control structure, LPS is the firm built around it.
Skytale Group is a boutique advisory that combines investment banking (M&A and capital raising) with management consulting and private-capital work, covering healthcare including dental explicitly, and it states it serves clients "from single location owners to sponsor-backed national platforms." A useful disclosure fact it publishes on its own site: Skytale's principals are registered investment-banking agents with Burch & Company, Inc. (a FINRA/SIPC member). It does not publish fees, and its fetched page does not state a headquarters. For a group that wants advisory plus operational consulting under one roof, Skytale spans both.
Provident Healthcare Partners (Boston) is a founder-owned healthcare investment bank doing sell-side M&A and financing, with dental and DSO as an active vertical inside a broader healthcare practice, and a buyer universe it describes as "private equity firms and strategic consolidators." Provident sits at the overlap between this dental bench and the national healthcare bench — it is one of the firms that appears in both this guide and the best healthcare M&A advisors guide, and for a dental group large enough to be a genuine platform, its private-equity relationships are the point.
Viper Equity Partners provides growth and transition consultation focused on aligning practices with DSOs and private equity, and it states it has "exclusive relationships with private equity-funded dental service organizations." Its site carries a "97% closing rate" claim, which is the firm's own marketing figure and should be read as such rather than as an independently verified statistic. For an owner who wants a firm oriented specifically around DSO and PE alignment, Viper is positioned there — just weigh the self-published performance claims accordingly.
Practice Exchange (Providence, Rhode Island) is a national sell-side advisory representing dental owners in transactions with DSOs, mini-DSOs (which it describes as "10 to 50 practices"), and IDSOs, with a Northeast and Mid-Atlantic core it says is "actively expanding nationally." Two facts define it. First, it is seller-exclusive: it states it represents "dental practice owners exclusively (never buyers)." Second, it publishes fee language: "No upfront fees. Success fee only." For an owner who wants an advisor that structurally only ever sits on the seller's side, with a stated success-fee-only model, Practice Exchange is explicit about both.
McLerran & Associates is a dental-specific sell-side M&A and brokerage firm that bridges the two tiers of this guide — it does both brokerage work and competitive-process advisory for DSO affiliations, which is why I place it here rather than with the transition brokers. It describes itself as, in its words, "The Industry Leader in Dental Practice Sales and Sell-Side Advisory for DSO Affiliations" and markets itself as a seller-side advocate with "35 years" of experience. Its site cites "1,500+ Successful Practice Sales" — a self-published figure, attributed. For an owner who wants a dental-only firm comfortable running either a straightforward sale or a competitive DSO process, McLerran spans both models.
How does the transition-broker model actually work?
A transition broker runs many confidential listings at once and matches each practice to buyers already in its database, which is a fundamentally different operating model from the bespoke, one-off competitive auction a sell-side advisor builds for a single platform. Understanding the model tells you what you are actually buying — and where its limits are.
The mechanics are consistent across the broker bench. A broker starts with a valuation, then markets the practice under a blind profile — region, collections band, high-level story, no practice name — so no one, least of all a competitor, can identify you from the listing. Interested buyers must accept an NDA before any detailed financials load. The broker then introduces you to pre-qualified buyers from a pool it already maintains, which is why database depth is a selling point these firms advertise: US Dental Transitions, for instance, describes a database of more than 125,000 dentists on its site. The broker manages the introductions, helps structure the deal, and shepherds it toward close.
The advantage of this model is speed and a warm buyer pool. Because the broker already knows buyers actively looking in your area and price band, a match can come together quickly, and for a solo practice selling to a local dentist, that efficiency is often exactly what you want. The trade-off is auction breadth and competitive tension. A matchmaking process introduces you to buyers the broker knows; it does not necessarily run the kind of broad, structured, multi-bidder competition that a sell-side advisor builds to drive DSO buyers against each other on price. For a practice that could genuinely attract several competing DSO bids, that competitive tension is worth real money, which is the entire argument for the advisory tier at scale.
There is one more feature of the model worth naming for the advisors and brokers reading this, because it shapes the tooling: a working transition broker or sell-side advisor typically runs five to fifteen confidential mandates at once. Each one is a separate practice with a separate blind profile, a separate buyer set, and separate financials that must never bleed into another listing. The operating discipline that makes that safe is one isolated, walled-off document room per mandate — which is a data-room problem, and the one I will come back to in the confidentiality section.
How do you vet a dental practice broker or advisor?
Vet on three axes — dental deal volume, who pays the firm, and the marketing process — and treat the conflict question as the heart of it, because dental representation splits three ways and each firm states its own model on its own site. The fee is the last thing to screen on, not the first, and only for firms that actually publish one.
Start with track record in your exact lane. Ask how many dental practices comparable to yours — same size band, same buyer type, same geography — the firm has actually closed in the last 18 months, and ask for references you can call. A firm that sells solo practices to individual dentists all day is learning on your dime if you hand it a five-location competitive DSO process, and vice versa. Where a firm publishes track-record figures, remember they are self-reported: several firms above cite their own transaction counts, and those are the firm's claims, not audited statistics.
Then the axis that matters most: who pays the firm, and whose side is it on? Dental representation falls into three models, and each firm here states its own on its own site, so you can and should resolve this before you sign:
- Supplier-owned. Henry Schein Dental Practice Transitions is the transitions arm of the dental distributor Henry Schein, Inc. Ask how the transitions business relates to the distribution business, and who it represents in your deal.
- Dual representation. AFTCO and PARAGON both describe representing buyer and seller in the same transaction — AFTCO frames it as "Equitable Transactions through Dual Representation," PARAGON as "win/win transactions." That is a legitimate, long-standing model, but the firm is not exclusively your advocate.
- Seller-exclusive. Practice Exchange states it represents owners and "never buyers." TUSK states it is "conflict-free" with "no financial ties or investments from DSOs." McLerran positions itself as a sell-side "advocate." If single-sided representation matters to you, these firms are explicit about it.
None of these three models is automatically disqualifying — plenty of dentists sell well through a supplier-affiliated or dual-representation broker. The point is to know which one you are hiring, ask directly who pays the firm and whether it ever represents the buyer, and price that into your decision. A dual-representation broker who is upfront about it is more trustworthy than a firm that is vague about whose side it is on.
Finally, the marketing process and — only where published — the fee. Confirm how the firm markets the practice (blind profile, NDA gate, staged reveal — the confidentiality mechanics in the next section), and confirm the fee basis for the four firms that publish it: Professional Transition Strategies ("only one broker fee," 30-day agreements), CTC Associates ("less than 10% of the selling price"), Practice Exchange ("success fee only"), and TUSK ("no retainers, paid at close"). For every other firm, the honest answer is that fee structures vary and you should ask directly, then get it in writing in the engagement letter. Never assume a typical commission a firm has not stated — the number varies too much, and inventing one only sets you up to be surprised. The general buyer's-eye view of what diligence will test is in our dental due diligence checklist, and the broader preparation posture is in our sell-side due diligence guide.
How do dental advisors keep a practice sale confidential across a dozen buyers?
A dental practice sale is a confidential process run against multiple buyers who must see your financials without your staff, your patients, or the practice down the street finding out — so it runs on a blind profile, an NDA gate, a staged reveal, per-viewer watermarks, and one-click revoke. This is the part of the sale that is natively a data-room problem, and it is worth being precise about who you are protecting against.
The threat model is concrete. Staff who fear a new owner start interviewing, and the most employable leave first. Patients who hear a rumor drift to the practice nearer their home, and that attrition shows up in the trailing collections a buyer underwrites. Referring specialists who hear you are selling, and do not know to whom, hedge by routing cases elsewhere. And competitors — the practice across town — are exactly the party that shows up as a "plausible buyer," which is what makes them dangerous: get a rival into your process and it learns your patient volume, your payer mix, your margins, and your staffing costs, then uses every bit of it against you. A leak is not embarrassment; it is a smaller practice sold at a lower multiple, or a dead deal.
The controls that hold the downside off are the same across every credible firm above, run in sequence: market with a blind profile so nobody can identify you from the listing; gate every buyer behind an NDA before any document loads; release sensitive financials by hand, buyer by buyer, only to parties you have vetted; serve documents view-only and watermarked with each viewer's name and email so a leaked page traces to one person; and revoke access in one click the instant a buyer looks like a competitor. When a broker or advisor is running several DSO bidders in parallel, these controls are what make it safe to keep each bidder walled off from the others — one isolated room per mandate, and one isolated view per buyer inside it.
The dental-native version of this build — the folder-by-folder document checklist, the staff-invisible confidentiality mechanics, and how to run several DSO bidders in parallel on per-buyer links — is covered in depth in our dental practice sale data room guide, and the generic clinic version, with physio and chiro examples, is in our clinic sale data room guide. One honest boundary, because it is the credibility test: if you are selling to a single associate you already trust, you need almost none of this. There is no competitor to guard against and no NDA triage to run — a shared folder and a good accountant may genuinely be enough. The confidentiality machine earns its keep when you are running a competitive process against multiple outside buyers, at least one of whom might be a rival. Match the tooling to the process.
Where does the software fit, honestly?
I run Peony, a data room company, so I will be direct about where it fits and where it does not. The brokers and advisors above are the people who sell your practice; a data room is the document layer they and you run the confidential process in. Its job is narrow and real: gate each buyer behind an NDA, serve financials view-only, watermark every page with the viewer's identity so a leaked page traces to one person, log who read what, and let an advisor keep five to fifteen mandates walled off in one room each. On the pricing point specifically — because practice owners ask — per-viewer dynamic watermarking sits on the Data Room plan at $52 per admin per month; the $30 Business plan carries the Simple NDA gate and one-click revoke; link expiry is on every tier, including the free plan, which covers up to 50 documents. We serve 6,800+ customers on exactly this document layer, but the software is not the deal — the advisor's buyer relationships and process are, and a clean, staged room simply makes their work faster and more competitive. If you are doing a simple internal sale, you may not need any of it, and I would rather say so than sell you a tier you will not use.
The bottom line
There is no single best dental M&A advisor, because the market is segmented by size and by model. For a solo-to-small-group sale, the transition brokers list and match: the national names that describe their own coverage include Henry Schein Dental Practice Transitions (supplier-owned), ddsmatch, AFTCO (dual representation), Professional Transition Strategies (publishes fees), US Dental Transitions, Omni Practice Group (not dental-exclusive), and PARAGON (dual representation), with CTC Associates covering the Mountain West and Practice Impact covering Ohio. For a group running a competitive DSO or platform process, the sell-side advisors take over: TUSK Practice Sales (over $1.5M revenue floor, conflict-free), Large Practice Sales (IDSO majority recaps), Skytale Group, Practice Exchange (seller-exclusive, success fee only), McLerran & Associates, plus Provident Healthcare Partners and Viper Equity Partners — and the largest multi-site platforms move up to the healthcare investment banks in the sibling guide.
The single most useful question is not "who is best?" but "who is this firm actually working for, and does it run my size of deal?" Resolve the conflict axis — supplier-owned, dual representation, or seller-exclusive — from each firm's own words, confirm recent dental deal volume in your exact lane, and get the fee in writing rather than assuming a number the firm never stated. We serve 6,800+ customers on the document side of exactly these processes, and the prep you do before you pick a firm — a defensible valuation, clean financials, and a staged, watermarked room — compounds everything the broker or advisor does next.
Related resources
- How to sell a dental practice — the valuation and process guide: what your practice is worth as a % of collections and on EBITDA, the six-to-nine-month timeline, and who buys in 2026
- DSO offer evaluation guide — how to read a specific DSO offer: EBITDA recast, cash-versus-rollover-versus-earnout, JV equity, and the red flags
- Dental practice sale data room — the dental-native room build: the folder-by-folder document checklist, staff-invisible confidentiality, and multi-DSO bid tracking
- Dental due diligence checklist — the buyer's verification lens: chart audit, hygiene math, PPO write-off reality, and the embezzlement screen
- Best healthcare M&A advisors — the broader healthcare bench above these dental firms: the national multi-vertical investment banks, including Provident, Cross Keys, and Physician Growth Partners for large multi-site PPM and DSO deals
- Best accounting firm M&A advisors — the sibling vertical directory for owners with mixed practices: CPA-firm advisors and practice brokers on the same size-tiered pattern
- Clinic sale data room guide — the confidential-sale playbook for any clinic: blind profile, NDA gate, staged reveal, and buyer-triage analytics
- Sell-side due diligence — preparing your own house before a buyer's diligence starts
Frequently asked questions
Do I need a dental practice broker or an M&A advisor to sell my practice?
It depends almost entirely on size and buyer type. A solo-to-small-group practice selling to another dentist or fielding a DSO approach is usually served by a dental practice transition broker, which runs a listings-and-matchmaking model against a buyer pool it already knows. A group or platform generating a few million dollars of EBITDA that wants a competitive process across multiple DSO and private-equity buyers is usually served by a dental M&A advisor running a structured sell-side process. The rough dividing line the market uses: at the small end, brokers list and match; above roughly $1.5M of revenue, sell-side advisors such as TUSK Practice Sales state they will run a competitive process, and platform-scale groups move to investment-bank-style advisories. The honest exception is an internal sale to an associate you already trust, where you may need neither a broker nor an advisor beyond a good transition attorney and CPA. Match the intermediary to the deal, not to the title.
Who are the dental practice transition brokers, and what size practice do they serve?
The national and large-regional transition brokers handle solo-to-small-group sales on a listings model. Firms that describe national coverage on their own sites include Henry Schein Dental Practice Transitions (the transitions arm of the distributor Henry Schein, with consultants it says cover all 50 states plus Washington, D.C.), ddsmatch, AFTCO (founded 1968, which describes itself as the oldest and largest dental transition consulting network), Professional Transition Strategies, US Dental Transitions (founded 1998, Suwanee, Georgia), Omni Practice Group (not dental-exclusive), and PARAGON Dental Practice Transitions. Two are explicitly regional: CTC Associates covers the Mountain West, and Practice Impact covers Ohio. Most publish no fee schedule; Professional Transition Strategies and CTC Associates are exceptions that describe their fee approach on their sites. These firms fit a practice selling to an individual dentist or a single DSO approach, not a platform running a full auction.
Who advises on DSO-scale and dental platform deals?
Once a group is large enough to attract competitive DSO and private-equity interest, the sell-side advisory tier takes over, running a structured process rather than a listing. Dental-focused firms that describe this model on their own sites include TUSK Practice Sales, which states it is the exclusive sell-side advisor for owners generating over $1.5M of revenue; Large Practice Sales, which specializes in the Invisible Dental Support Organization structure where a buyer takes a majority stake while the doctor keeps operational control; Skytale Group, a boutique advisory whose principals are registered investment-banking agents; Practice Exchange, which represents dental owners exclusively on a success-fee-only basis; and McLerran & Associates, a dental sell-side advisory that bridges brokerage and DSO-affiliation work. Provident Healthcare Partners and Viper Equity Partners also work dental among broader healthcare mandates. For the broader healthcare investment banks that handle the largest multi-site platform deals, see our best healthcare M&A advisors guide.
How does the dental transition-broker model actually work?
A transition broker runs many confidential listings at once and matches each to buyers already in its database, rather than building a bespoke auction for a single practice. The typical flow is a valuation, a blind profile that markets your practice by region and collections band without naming it, an NDA gate before any buyer sees detailed financials, and introductions to pre-qualified buyers from a pool the broker maintains. US Dental Transitions, for example, describes a database of more than 125,000 dentists on its site. The upside is speed and a warm buyer pool; the trade-off versus a full advisory process is auction breadth and competitive tension. For a solo practice selling to a local dentist, the matchmaking model is often exactly right. For a group that could draw six competing DSO bids, a structured sell-side advisor is usually the better fit because the competition is what moves the price.
How do I vet a dental practice broker or M&A advisor?
Screen on three things: recent dental deal volume, who pays the firm, and the marketing process. First, ask how many dental practices like yours the firm has actually closed in the last 18 months, and ask for references you can call. Second, resolve the conflict question directly, because dental representation splits three ways and each firm states its own model on its site: some brokers are affiliated with a supplier (Henry Schein Dental Practice Transitions is the transitions arm of the distributor Henry Schein), some practice dual representation of both buyer and seller (AFTCO and PARAGON describe this on their sites), and some are seller-exclusive (Practice Exchange states it represents owners and never buyers, TUSK states it has no financial ties to DSOs, and McLerran positions itself as a sell-side advocate). None of these is automatically disqualifying, but you should know which one you are hiring and ask who pays the firm and whether it ever represents the buyer. Third, confirm the confidentiality mechanics and, only for firms that publish fee language, the fee basis. Never assume a typical commission a firm has not stated.
How do dental advisors keep a practice sale confidential across multiple buyers?
They run the sale as a confidential process against buyers who never learn your identity until they have earned it. The standard controls are a blind profile that markets the practice by region and collections band with no name, an NDA that every buyer must accept before any document loads, a staged reveal that releases detailed financials only to vetted buyers, per-viewer watermarking so a leaked page traces to one person, and one-click revocation the instant a buyer looks like a competitor. This matters most when a broker or advisor is running several DSO bidders in parallel and cannot afford to let a rival practice across town see your patient volume, payer mix, and margins. A solo sale to a trusted associate needs almost none of this. The confidentiality machine earns its keep when you are running a competitive process against multiple outside buyers, at least one of whom might be a rival. The dental-native build is in our dental practice sale data room guide.
What data room do dental M&A advisors use for practice sales?
Dental transition brokers and sell-side advisors run confidential practice sales in a virtual data room that gates each buyer behind an NDA, serves financials view-only, watermarks every page with the viewer's identity, and logs who read what. That is exactly what I built Peony to do, and it now serves 6,800+ customers across M&A, fundraising, and diligence workflows, including practice owners and their advisors running confidential sales. The practitioner pattern is one isolated room per mandate: an advisor juggling five to fifteen concurrent listings keeps each practice's documents walled off from the others. On pricing, per-viewer dynamic watermarking sits on the $52-per-admin-per-month Data Room plan; the $30 Business plan carries the Simple NDA gate and one-click revoke; link expiry is on every tier, including the free plan (which covers up to 50 documents). A single associate buyer you already trust needs almost none of this, so match the tooling to the process. Peony is the document layer, not the advisor, and with 6,800+ customers the pattern we see most is that a clean, staged room makes the advisor's process faster and more competitive.
Do dental brokers publish their fees, and what should I expect to pay?
Most do not publish fees, and you should not assume a number a firm has not stated. Four firms describe their fee approach on their own sites: Professional Transition Strategies states there are no upfront costs or retainer fees, only one broker fee, on 30-day listing agreements; CTC Associates describes an adjusted percentage option it says normally equates to less than 10% of the selling price; Practice Exchange states no upfront fees and a success fee only; and TUSK Practice Sales states no retainers, paid at close. Every other firm named here is silent on fees, which means the honest answer for those firms is that fee structures vary and you should ask directly, then get the arrangement in writing in the engagement letter. Two things to pin down regardless of headline rate: how the fee base is defined, and whether any retainer is credited against the success fee. The fee delta between two credible firms is usually smaller than the price delta a well-run competitive process produces.
Should I use a dental-specific advisor or a general healthcare investment bank?
Match the firm to your scale. A single practice or a small group is best served by a dental transition broker or a dental sell-side advisor that lives in the practice-transition market every day and knows the DSO buyer pool. A large multi-site dental platform doing a competitive process or a recapitalization is often better served by, or runs alongside, a healthcare investment bank with a dental or DSO practice, because those firms bring the private-equity and strategic-buyer relationships and the process machinery a platform deal needs. The two tiers are complementary, not competing: the broader healthcare bench, including Provident Healthcare Partners, Cross Keys Capital, and Physician Growth Partners for large multi-site physician-practice-management and DSO deals, is mapped in our best healthcare M&A advisors guide. This guide owns the dental-specific bench and the size framework; that one owns the national multi-vertical healthcare bench.
About the author: Sean Yu is the co-founder of Peony, the data room platform used by 6,800+ customers across M&A, fundraising, and diligence workflows — including dental practice owners, transition brokers, and sell-side advisors running confidential practice sales. Before Peony, Sean spent his career on the deal side — M&A at Nomura, early-stage VC at Backed VC, and growth-equity / secondaries at Target Global — running and supporting sell-side and buy-side processes across healthcare, software, and industrials in North America and Europe. He studied Biomedical Engineering at Imperial College London on a full scholarship before dropping out to build companies. Contact: sean@peony.ink • LinkedIn.
You might also like
Aug 26, 2026
Dental Practice Sale Data Room: The 2026 Seller's Document and Confidentiality Playbook
Aug 25, 2026
How to Sell a Dental Practice in 2026: Valuation, Process, and Exit Paths
Aug 25, 2026
Should You Sell Your Dental Practice to a DSO? How to Evaluate the Offer (2026)

